PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -50.8% | 1,030 | -33.3% | 0.00% | – |
| Q1 2023 | $63 | -100.0% | 1,544 | -53.0% | 0.00% | – |
| Q1 2022 | $250,000 | +5.9% | 3,282 | -16.6% | 0.00% | – |
| Q4 2021 | $236,000 | +23.6% | 3,934 | +7.9% | 0.00% | – |
| Q2 2020 | $191,000 | +37.4% | 3,645 | -12.5% | 0.00% | – |
| Q1 2020 | $139,000 | +275.7% | 4,168 | +410.2% | 0.00% | – |
| Q4 2019 | $37,000 | -73.4% | 817 | -77.7% | 0.00% | – |
| Q3 2019 | $139,000 | – | 3,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |